Jove
Visualize
お問い合わせ
JoVE
x logofacebook logolinkedin logoyoutube logo
JoVEについて
概要リーダーシップブログJoVEヘルプセンター
著者向け
出版プロセス編集委員会範囲と方針査読よくある質問投稿
図書館員向け
推薦の声購読アクセスリソース図書館諮問委員会よくある質問
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experimentsアーカイブ
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教員リソースセンター教員サイト
利用規約
プライバシーポリシー
ポリシー

関連する概念動画

Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Adaptive Mechanisms in Cancer Cells02:53

Adaptive Mechanisms in Cancer Cells

6.0K
Cancer cells accumulate genetic changes at an abnormally rapid rate due to the defects in the DNA repair mechanisms. From an evolutionary perspective, such genetic instability is advantageous for cancer development. Mutant cell lines accumulate a series of beneficial mutations that contribute to their progression into cancer.
Some of the advantages that cancer cells have on normal cells include - enhanced ability to divide without terminally differentiating, induce new blood vessel formation,...
6.0K
Electron Transport Chain: Complex I and II01:46

Electron Transport Chain: Complex I and II

15.2K
The mitochondrial electron transport chain (ETC) is the main energy generation system in the eukaryotic cells. However, mitochondria also produce cytotoxic reactive oxygen species (ROS) due to the large electron flow during oxidative phosphorylation. While Complex I is one of the primary sources of superoxide radicals, ROS production by Complex II is uncommon and may only be observed in cancer cells with mutated complexes.
ROS generation is regulated and maintained at moderate levels necessary...
15.2K
Targeted Cancer Therapies02:57

Targeted Cancer Therapies

7.9K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
7.9K
Cancer Therapies02:49

Cancer Therapies

8.0K
Cancer therapies are various modes of treatment, such as surgery, radiation therapy, and chemotherapy that are administered to cancer patients.
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
8.0K

こちらも読む

関連記事

共著者、ジャーナル、引用グラフによってこの研究に関連する記事。

並び替え
Same author

Meloxicam-1-d-MT Dual-Drug Hydrogel Serves as an Immunomodulator to Reverse Tumor Postoperative Recurrence and Metastasis.

ACS applied materials & interfaces·2026
Same author

A Self-Assembled Irinotecan Nanomedicine Abrogates Steatohepatitis-Induced Liver Metastasis and Potentiates Antitumor Efficacy against Colorectal Cancer.

ACS nano·2026
Same author

Manganese-engineered Lactobacillus Reuteri with enhanced antitumor and immunomodulatory activities for colorectal cancer prevention and treatment.

Nature communications·2025
Same author

Correction to "Sericin Nerve Guidance Conduit Delivering Therapeutically Repurposed Clobetasol for Functional and Structural Regeneration of Transected Peripheral Nerves".

ACS biomaterials science & engineering·2025
Same author

Engineering of a Mantis-Forelimb-Inspired Bioabsorbable Lens-like Ocular Therapeutic (BLOT) Device for Effective Bacterial Keratitis Treatment.

Nano letters·2025
Same author

Bioactive Silk Sericin/Bioceramic Nerve Guidance Conduit for Effective Repair of Long-Gap Transected Peripheral Nerve Injury through Regulating Schwann Cells.

Advanced science (Weinheim, Baden-Wurttemberg, Germany)·2025

関連する実験動画

Updated: Oct 2, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.3K

銅ベースの金属有機構造は,動的にバランスのとれた細胞リドックスホメオスタシスをシステム的に破壊することによって,がんの化学抵抗を克服する.

Jia Liu1, Ye Yuan1,2, Yanni Cheng1

  • 1Research Center for Tissue Engineering and Regenerative Medicine, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Journal of the American Chemical Society
|February 22, 2022
PubMed
まとめ

新しい銅基金属有機フレームワーク (CuHPT) は,薬剤耐性がん細胞を標的とし,その酸化還元恒常性を破壊し,酸化ストレスを誘発し,がん細胞を選択的に殺します. このアプローチは,化学抵抗を克服するための臨床前モデルの有意な可能性を示しています.

さらに関連する動画

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

601
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.0K

関連する実験動画

Last Updated: Oct 2, 2025

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks
04:53

Author Spotlight: Advances in Evaluating Human Lung Epithelial Cells' Response to Metal-Organic Frameworks

Published on: May 26, 2023

1.3K
Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism
05:36

Author Spotlight: Assessing the Impact of Novel Iron Chelators on Cancer Cell Metabolism

Published on: February 23, 2024

601
Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay
11:14

Anticancer Metal Complexes: Synthesis and Cytotoxicity Evaluation by the MTT Assay

Published on: November 10, 2013

58.0K

科学分野:

  • 生物医学工学
  • 材料科学
  • 腫瘍学

背景:

  • 化学薬品耐性はがんの再発の主な要因で 複雑な細胞メカニズムによって悪化することが多い
  • 従来の治療法では 耐性がんに対して 失敗することが多く 時には代替治療法によって 耐性を促進することさえあります

研究 の 目的:

  • 薬剤耐性の癌細胞の 独特の生化学的脆弱性を標的とした 新しい治療剤を設計する
  • 化学薬品耐性を克服するための銅基金属有機構造 (CuHPT) の可能性を調査する.

主な方法:

  • ナノサイズの銅/カテコール基の金属有機枠組 (CuHPT) の開発
  • ガン細胞内でグルタチオン (GSH) によって誘発されるCuHPTの分解メカニズムの調査.
  • ROS生成とGSH減少による酸化ストレスを誘発するCuHPTの能力の評価.
  • 薬剤耐性がん細胞に対するCuHPTの細胞毒性の評価 in vitro および in vivo 腫瘍成長抑制.

主要な成果:

  • CuHPTは薬剤耐性細胞で選択的に分解し,銅イオンとカテキルリガンドを放出する.
  • 分解は,GSHを枯渇させ,酸化ストレスを引き起こすことで,細胞内活性酸素種 (ROS) の生成を拡大する.
  • CuHPTは,複数の薬剤耐性がん細胞系に対して強力で選択的な細胞毒性を示した.
  • 生体内試験では,CuHPTは腫瘍の成長を効果的に抑制し,マウスの生存率を大幅に改善しました.

結論:

  • CuHPTは薬剤耐性の癌細胞の 還元性恒常性を正確に分解することで 賢い治療薬として作用します
  • この新しい銅ベースのMOFは,化学抵抗を克服し,がん治療結果を改善するための有望な戦略を提供します.